{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:48:14Z","timestamp":1765889294582},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ijcard.2024.132098","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T15:18:09Z","timestamp":1714144689000},"page":"132098","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Trends in percutaneous left atrial appendage occlusion and 1-year mortality 2013\u20132021: A nationwide observational study"],"prefix":"10.1016","volume":"408","author":[{"given":"Olivia J.","family":"Madsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Lamberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas B.","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten L.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"K\u00fcmler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik L.","family":"Grove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels H.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emil","family":"Fosb\u00f8l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarl E.","family":"Strange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijcard.2024.132098_bb0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"issue":"13","key":"10.1016\/j.ijcard.2024.132098_bb0010","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update","volume":"15","author":"Glikson","year":"2020","journal-title":"EuroIntervention"},{"issue":"9689","key":"10.1016\/j.ijcard.2024.132098_bb0015","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijcard.2024.132098_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy","volume":"64","author":"Holmes","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"10.1016\/j.ijcard.2024.132098_bb0025","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2024.132098_bb0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jce.14804","article-title":"Contemporary procedural trends of Watchman percutaneous left atrial appendage occlusion in the United States","volume":"32","author":"Munir","year":"2021","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"11","key":"10.1016\/j.ijcard.2024.132098_bb0035","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jcin.2019.04.002","article-title":"5-year experience of in-hospital outcomes after percutaneous left atrial appendage closure in Germany","volume":"12","author":"Hobohm","year":"2019","journal-title":"JACC Cardiovasc. Interv."},{"issue":"13","key":"10.1016\/j.ijcard.2024.132098_bb0040","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2019.12.040","article-title":"The NCDR left atrial appendage occlusion registry","volume":"75","author":"Freeman","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"14","key":"10.1016\/j.ijcard.2024.132098_bb0045","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","article-title":"Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation","volume":"71","author":"Fauchier","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2024.132098_bb0050","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/ehjqcco\/qcab042","article-title":"Left atrial appendage occlusion in the UK: prospective registry and data linkage to hospital episode statistics","volume":"7","author":"Willits","year":"2021","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes."},{"issue":"7","key":"10.1016\/j.ijcard.2024.132098_bb0055","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jcin.2022.02.009","article-title":"Clinical outcomes at 1 year following transcatheter left atrial appendage occlusion in the United States","volume":"15","author":"Price","year":"2022","journal-title":"JACC Cardiovasc. Interv."},{"issue":"9","key":"10.1016\/j.ijcard.2024.132098_bb0060","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","article-title":"Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial","volume":"14","author":"Boersma","year":"2017","journal-title":"Heart Rhythm."},{"issue":"7_suppl","key":"10.1016\/j.ijcard.2024.132098_bb0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish civil registration system","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand. J. Public Health"},{"issue":"7_suppl","key":"10.1016\/j.ijcard.2024.132098_bb0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish national patient register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand. J. Public Health"},{"issue":"3","key":"10.1016\/j.ijcard.2024.132098_bb0075","article-title":"Data resource profile: the Danish national prescription registry","volume":"46","author":"Potteg\u00e5rd","year":"2016","journal-title":"Int. J. Epidemiol."},{"issue":"7 Suppl","key":"10.1016\/j.ijcard.2024.132098_bb0080","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/1403494811404278","article-title":"The national diabetes register","volume":"39","author":"Carstensen","year":"2011","journal-title":"Scand. J. Public Health"},{"key":"10.1016\/j.ijcard.2024.132098_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"issue":"10132","key":"10.1016\/j.ijcard.2024.132098_bb0090","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","article-title":"Development and validation of a hospital frailty risk score focusing on older people in acute care settings using electronic hospital records: an observational study","volume":"391","author":"Gilbert","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijcard.2024.132098_bb0095","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.ijcard.2024.132098_bb0100","series-title":"R: A Language and Environment for Statistical Computing","author":"R CT","year":"2018"},{"key":"10.1016\/j.ijcard.2024.132098_bb0105","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.123.010279","article-title":"Patient characteristics associated with using transcatheter left atrial appendage occlusion versus oral anticoagulants for atrial fibrillation","volume":"17","author":"Lin","year":"2024","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"11","key":"10.1016\/j.ijcard.2024.132098_bb0110","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamacardio.2021.3021","article-title":"Sex differences in procedural outcomes among patients undergoing left atrial appendage occlusion: insights from the NCDR LAAO registry","volume":"6","author":"Darden","year":"2021","journal-title":"JAMA Cardiol."},{"issue":"21","key":"10.1016\/j.ijcard.2024.132098_bb0115","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.jcin.2022.06.037","article-title":"Sex differences in safety and effectiveness of LAAO: insights from the amulet IDE trial","volume":"15","author":"Alkhouli","year":"2022","journal-title":"JACC Cardiovasc. Interv."},{"issue":"3","key":"10.1016\/j.ijcard.2024.132098_bb0120","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.acvd.2022.12.007","article-title":"Initiation and development of a percutaneous left atrial appendage closure programme: a French centre\u2019s experience and literature review","volume":"116","author":"Albert","year":"2023","journal-title":"Arch. Cardiovasc. Dis."},{"issue":"5","key":"10.1016\/j.ijcard.2024.132098_bb0125","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.hrthm.2022.01.007","article-title":"Frailty in patients undergoing percutaneous left atrial appendage closure","volume":"19","author":"Wang","year":"2022","journal-title":"Heart Rhythm."},{"issue":"16","key":"10.1016\/j.ijcard.2024.132098_bb0130","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.jcin.2021.06.008","article-title":"The association of chronic kidney disease with outcomes following percutaneous left atrial appendage closure","volume":"14","author":"Ahuja","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"issue":"23","key":"10.1016\/j.ijcard.2024.132098_bb0135","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013525","article-title":"Net clinical benefit of left atrial appendage closure versus warfarin in patients with atrial fibrillation: a pooled analysis of the randomized PROTECT-AF and PREVAIL studies","volume":"8","author":"Brouwer","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"9","key":"10.1016\/j.ijcard.2024.132098_bb0140","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jacc.2017.07.724","article-title":"Cerebral amyloid angiopathy","volume":"70","author":"DeSimone","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"13_Supplement","key":"10.1016\/j.ijcard.2024.132098_bb0145","article-title":"TCT-742 percutaneous left atrial appendage closure following transcatheter aortic valve replacement: results from the ATTRACTIVE study","volume":"72","author":"Wong","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2024.132098_bb0150","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/europace\/euac181","article-title":"Combined atrial fibrillation ablation and left atrial appendage occlusion procedure in the United States: a propensity score matched analysis from 2016\u20132019 national readmission database","volume":"25","author":"Pasupula","year":"2022","journal-title":"EP Europace"},{"issue":"1","key":"10.1016\/j.ijcard.2024.132098_bb0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40620-020-00774-5","article-title":"Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis","volume":"34","author":"Genovesi","year":"2021","journal-title":"J. Nephrol."},{"issue":"19","key":"10.1016\/j.ijcard.2024.132098_bb0160","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ijcard.2024.132098_bb0165","doi-asserted-by":"crossref","first-page":"774","DOI":"10.4244\/EIJ-D-20-01309","article-title":"Incidence and clinical impact of major bleeding following left atrial appendage occlusion: insights from the Amplatzer Amulet observational post-market study","volume":"17","author":"Aminian","year":"2021","journal-title":"EuroIntervention"},{"issue":"10","key":"10.1016\/j.ijcard.2024.132098_bb0170","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/europace\/eux254","article-title":"Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey","volume":"19","author":"Tilz","year":"2017","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.ijcard.2024.132098_bb0175","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.008418","article-title":"Indications for left atrial appendage occlusion in the United States and associated in-hospital outcomes: results from the NCDR LAAO registry","volume":"15","author":"Daimee","year":"2022","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"4","key":"10.1016\/j.ijcard.2024.132098_bb0180","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1345\/aph.1K498","article-title":"Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls","volume":"42","author":"Garwood","year":"2008","journal-title":"Ann. Pharmacother."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324007204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324007204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T19:01:20Z","timestamp":1716922880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527324007204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":36,"alternative-id":["S0167527324007204"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132098","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in percutaneous left atrial appendage occlusion and 1-year mortality 2013\u20132021: A nationwide observational study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"132098"}}